The Emerging Role of Triggering Receptor Expressed on Myeloid Cells 2 as a Target for Immunomodulation in Ischemic Stroke
Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.01668
Full Text
Open PDFAbstract
Available in full text
Date
July 17, 2019
Authors
Publisher
Frontiers Media SA